Product Images Lamivudine And Zidovudine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Lamivudine And Zidovudine NDC 65862-036 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 150 mg/300 mg (60 Tablet Bottle) - lamizido fig1
This is a description of a medication labeled as the NDC 65862-036-60. The medication contains Lamivudine and Zidovudine in film-coated tablets. Each tablet consists of 150 mg of lamivudine USP and 300 mg of zidovudine USP. The usual dosage information can be found in the prescribing information, and it should not be used if the safety seal is broken or missing. This medication should be stored at a temperature range of 20° to 25°C (66° to 77°F); excursions are permitted to 15° to 30°C (59° o 86°F). It is distributed by Aurobindo Pharma USA, Inc. and made in India.*
lamizido fig2
This is a description of a prescription drug labeled "Lamivudine and Zidovudine Tablets USP," containing 150 mg of lamivudine and 300 mg of zidovudine in each film-coated tablet. It is distributed in the US by Aurobindo Pharma USA and should be stored at room temperature. The usual dosage is available in the prescribing information. The NDC number is 65862-036-10.*
Chemical Structure Lamivudine - lamizido str1
Chemical Structure Zidovudine - lamizido str2
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.